Qaqa AY, DeBari VA, Isbitan A., et al. The role of post-exercise measurements in the diagnosis of peripheral arterial disease in HIV-infected patients. Angiology. 2010 [In process citation].
2.
Carr A., Samaras K., Thorisdottir A., Kaufmann GR, Chisholm DJ, Cooper DADiagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353(9170): 2093-2099.
3.
Periard D., Telenti A., Sudre P., et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation . 1999;100(7):700-705.
4.
Maggi P., Serio G., Epifani G., et al. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS. 2000 ;14(16):F123-F128.
5.
Depairon M., Chessex S., Sudre P., et al. Premature atherosclerosis in HIV-infected individuals-focus on protease inhibitor therapy. AIDS. 2001;15(3):329-334.
6.
Mangili A., Gerrior J., Tang AM, et al. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium scores . Clin Infect Dis. 2006;43(11):1482-1489.
7.
DAD Study Group, Friis-Moller N., Reiss P., et al. Class of antiretroviral drugs and the risk of myocardial infarction . N Engl J Med. 2007;356(17):1723-1735.
8.
Periard D., Cavassini M., Taffe P., et al. High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis. 2008;46(5):761-767.
9.
Palacios R. , Alonso I., Hidalgo A., et al. Peripheral arterial disease in HIV patients older than 50 years of age. AIDS Res Hum Retroviruses . 2008;24(8):1043-1046.
10.
van Marle J. , Mistry PP, Botes K.HIV-occlusive vascular disease. S Afr J Surg. 2009;47(2):36-42.
11.
Jang JJ, Schwarcz AI, Amaez DA, et al. Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study. J Int AIDS Soc. 2010;13:12.
12.
Ye Y., Zeng Y., Li X., et al. HIV infection: an independent risk factor of peripheral arterial disease. J Acquir Immune Defic Syndr.2010 ;53(2):276-278.
13.
Maggi P., Perilli F., Lillo A., et al. An ultrasound-based comparative study on carotid plaques in HIV-positive patients vs. atherosclerotic and arthritis patients: atherosclerotic or inflammatory lesions? Coron Artery Dis. 2007;18(1):23-29.
14.
Maggi P., Perilli F., Lillo A., Volpe A., Pastore G., Regina G.B-mode ultrasound study of carotid plaques in HIV-positive patients to detect the presence of inflammatory endothelial lesions. Curr HIV Res.2009;7(5):541-546.
15.
Paraskevas KI, Mikhailidis DPC-reactive protein (CRP): more than just an innocent bystander? Curr Med Res Opin. 2008 ; 24(1):75-78.
16.
Athyros VG, Kakafika AI, Karagiannis A., Mikhailidis DPDo we need to consider inflammatory markers when we treat atherosclerotic disease? Atherosclerosis. 2008;200(1):1-12.
17.
Chetty R., Batitang S., Nair R.Large artery vasculopathy in HIV-positive patients: another vasculitic enigma . Hum Pathol. 2000;31(3):374-379.
18.
Barbaro G.HIV infection, highly active antiretroviral therapy and the cardiovascular system. Cardiovasc Res. 2003;60(1):87-95.
19.
Alnaeb ME, Alobaid N., Seifalian AM, Mikhailidis DP, Hamilton G.Statins and peripheral arterial disease: potential mechanisms and clinical benefits. Ann Vasc Surg. 2006;20(5):696-705.
20.
Paraskevas KI, Hamilton G., Mikhailidis DPStatins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007 ;46(2):373-386.
21.
Tsiara S., Elisaf M., Mikhailidis DPInfluence of smoking on predictors of vascular disease. Angiology . 2003;54(5):507-530.
22.
Kakafika AI , Mikhailidis DPSmoking and aortic diseases. Circ J.2007;71(8):1173-1180.
23.
Milionis HJ , Rizos E., Mikhailidis DPSmoking diminishes the beneficial effects of statins: observations from the landmark trials. Angiology . 2001;52(9):575-587.
24.
Doonan RJ, Hausvater A., Scallan C., Mikhailidis DP, Pilote L., Daskalopoulou SSThe effect of smoking on arterial stiffness. Hypertens Res.2010;33(5):398-410.
25.
Bernardino de la Serna JI, Zamora FX, Montes ML, García-Puig J., Arribas JRHypertension, HIV infection and highly active antiretroviral therapy. Enferm Infecc Microbiol Clin. 2010;28(1): 32-37.
26.
Grinspoon SKMetabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med. 2005; 118(suppl 2):23S-28S.
27.
Fine DM, Perazella MA, Lucas GM, Atta MGRenal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs. 2008;68(7):963-980.
28.
Sudano I., Spieker LE, Noll G., Corti R., Weber R., Luscher TFCardiovascular disease in HIV infection. Am Heart J. 2006; 151(6):1147-1155.
29.
Micheletti RG, Fishbein GA, Fishbein MC, et al. Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study. Cardiovasc Pathol.2009; 18(1):28-36.
30.
Micheletti RG, Fishbein GA, Currier JS, Singer EJ, Fishbein MCCalcification of the internal elastic lamina of coronary arteries. Mod Pathol . 2008;21(8):1019-1028.
31.
Zhang H., Li XY, Si YJ, Lu XL, Luo XS, Liu ZYManifestation of lower extremity atherosclerosis in diabetic patients with high ankle-brachial index. Chin Med J (Engl).2010;123(7): 890-894.
32.
Fabry P., Dubost JJ, Pochon P., Duchene-Marullaz P.Comparison of standard one-minute treadmill exercise and strandness test (absolute walking distance) in relation to site of lesion, walking distance, and diastolic blood flow velocity (Doppler curves). Angiology . 1990;41(10):869-876.
